Skip to content
Ozanezumab
Ozanezumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against reticulon-4.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Amyotrophic lateral sclerosisD000690EFO_0000253G12.21112
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Relapsing-remitting multiple sclerosisD020529EFO_000392911
Multiple sclerosisD009103EFO_0003885G3511
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOZANEZUMAB
INNozanezumab
Description
Ozanezumab (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID1310680-64-8
RxCUI
ChEMBL IDCHEMBL2108679
ChEBI ID
PubChem CID
DrugBankDB12891
UNII ID123I05210W (ChemIDplus, GSRS)
Target
Agency Approved
RTN4
RTN4
Organism
Homo sapiens
Gene name
RTN4
Gene synonyms
KIAA0886, NOGO
NCBI Gene ID
Protein name
reticulon-4
Protein synonyms
Foocen, Human NogoA, My043 protein, neurite growth inhibitor 220, Neurite outgrowth inhibitor, Neuroendocrine-specific protein, Neuroendocrine-specific protein C homolog, Nogo protein, NSP, reticulon 5, Reticulon-5, RTN-x
Uniprot ID
Mouse ortholog
Rtn4 (68585)
reticulon-4 (Q99P72)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 51 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details